St. Jude Children's Research Hospital
Memphis, TN USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Caution Needed for Drugs in Development for Most Common Malignant Pediatric Brain Tumor


Inhibiting the Ezh2 enzyme may be counterproductive for treatment of certain cancers, including the aggressive brain tumor Group 3 medulloblastoma
21-Mar-2017 1:25 PM EDT Add to Favorites

As Radiation Therapy Declined So Did Second Cancers in Childhood Cancer Survivors

Childhood cancer survivors are living longer. Now research shows they are also less likely to develop second cancers while still young. The decline followed a sharp drop in the use of radiation therapy for treatment of childhood cancers.
23-Feb-2017 3:05 PM EST Add to Favorites

Stephen Gottschalk, M.D., Has Been Named Chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital


Esteemed clinician and scientist will oversee one of the world’s largest pediatric bone marrow transplantation programs.
26-Jan-2017 6:05 PM EST Add to Favorites

Research Leads to New Treatment Recommendations for a High-Risk Pediatric Leukemia


International researchers led by St. Jude Children’s Research Hospital have identified genetic alterations that can be used to guide treatment of pediatric acute megakaryoblastic leukemia, which has a dismal prognosis.
19-Jan-2017 6:05 PM EST Add to Favorites

Infant’s Prolonged Infection Reveals Mutation That Helps Bacteria Tolerate Antibiotics


A life-threatening infection in an infant with leukemia led to a St. Jude Children’s Research Hospital discovery of how prolonged infection sets the stage for bacterial persistence despite antibiotic susceptibility.
29-Dec-2016 4:00 PM EST Add to Favorites

Loss of ARID1A Protein Drives Onset and Progress of Colon Cancer


St. Jude Children’s Research Hospital researchers and collaborators reveal how a tumor-suppressing protein interacts with genetic enhancers to silence cancer genes in a newly developed model system
12-Dec-2016 2:05 PM EST Add to Favorites

Prevalence of Ph-Like ALL in Adults Underscores Need for Genetic Testing, Clinical Trials


International research led by St. Jude Children’s Research Hospital shows the high-risk subtype Ph-like ALL accounts for almost 25 percent of ALL cases in adults and may be treatable with available targeted therapies.
21-Nov-2016 2:00 PM EST Add to Favorites

Patient Safety Benefits When Hospitals Provide Feedback to Staff Who Report Errors

A St. Jude Children’s Research Hospital analysis suggests that to improve patient safety, hospitals should focus on providing feedback to staff about changes resulting from past staff reports of safety-related events.
1-Nov-2016 10:10 AM EDT Add to Favorites

Our YouTube Videos

Chat now!